Huntington National Bank’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28 Sell
1
-52
-98% -$1.22K ﹤0.01% 3454
2026
Q1
$1.01K Buy
+53
New +$1.17K ﹤0.01% 2369
2025
Q4
Sell
-11
Closed -$281 4126
2025
Q3
$281 Sell
11
-51
-82% -$1.21K ﹤0.01% 2492
2025
Q2
$1.34K Buy
62
+51
+464% +$1.15K ﹤0.01% 2292
2025
Q1
$251 Sell
11
-212
-95% -$5.58K ﹤0.01% 2594
2024
Q4
$5.79K Sell
223
-124,424
-100% -$3.1M ﹤0.01% 1949
2024
Q3
$3.12M Hold
124,647
0.02% 277
2024
Q2
$2.67M Buy
124,647
+1,765
+1% +$34.3K 0.02% 287
2024
Q1
$2.28M Hold
122,882
0.02% 303
2023
Q4
$2M Hold
122,882
0.02% 315
2023
Q3
$1.7M Buy
+122,882
New +$1.94M 0.02% 323

Other funds holding BLFS

Huntington National Bank's BLFS Position: Q2 2026 in Review

Huntington National Bank reduced its BioLife Solutions (BLFS) stake by 98% in Q2 2026, selling an estimated $1.22K and leaving 1 share worth $28. The position accounts for ﹤0.01% of the portfolio, ranked #3454.

Huntington National Bank first reported a position in BLFS in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.12M in Q3 2024. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Huntington National Bank held 1 share of BioLife Solutions worth $28 as of Q2 2026.
  • Huntington National Bank sold 52 BioLife Solutions shares in Q2 2026, an estimated $1.22K.
  • BioLife Solutions made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #3454 holding.
  • Huntington National Bank first reported a position in BioLife Solutions in Q3 2023 and has held it in 11 quarters since.
  • Huntington National Bank's BioLife Solutions position peaked at $3.12M in Q3 2024.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.